A new type of treatment for osteoarthritis, currently in canine clinical trials, shows promise for eventual use in humans.
The treatment, developed by Cornell biomedical engineers, is a synthetic version of a naturally occurring joint lubricant that binds to the surface of cartilage in joints and acts as a cushion during high-impact activities, such as running.
“When the production of that specific lubricant goes down, it creates higher contact between the surfaces of the joint and, over time, it leads to osteoarthritis,” said David Putnam, a professor in the College of Engineering with appointments in the Meinig School of Biomedical Engineering and the Smith School of Chemical and Biomolecular Engineering.
Putnam is senior author of “Boundary Mode Lubrication of Articular Cartilage With a Biomimetic Diblock Copolymer,” published June 4 in Proceedings of the National Academy of Sciences, USA. Zhexun Sun, a postdoctoral researcher in Putnam’s lab, is the paper’s first author.
The study focuses on a naturally occurring joint lubricant called lubricin, the production of which declines following traumatic injuries to a joint, such as a ligament tear in a knee.
The knee is lubricated in two ways – hydrodynamic mode and boundary mode.
Hydrodynamic mode lubrication occurs when the joint is moving fast and there isn’t a strong force pushing down on it. In this mode, joints are lubricated by compounds like hyaluronic acid (HA) that are thick and gooey, like car oil. There are numerous HA products on the market, approved by the Food and Drug Administration, for treating hydrodynamic mode lubrication disorders.
But HA is ineffective when strong forces are pushing down on the joint, such as those that occur during running or jumping. In these instances, thick gooey HA squirts out from between the cartilage surfaces, and boundary mode lubrication is necessary. Under these forces, lubricin binds to the surface of the cartilage. It contains sugars that hold on to water, to cushion hard forces on the knee.
In the paper, the researchers describe a synthetic polymer they developed that mimics the function of lubricin and is much easier to produce. “We are in clinical trials, with dogs that have osteoarthritis, with our collaborators at Cornell’s College of Veterinary Medicine,” Putnam said.
Those collaborators – Ursula Krotscheck and Kei Hayashi, both associate professors in the Section of Small Animal Surgery in the Department of Clinical Sciences – use a force plate to measure the efficacy of the treatments. The force plate quantifies the amount of force that a dog exerts with each paw, to measure whether they are favoring one paw over another.
“Once we finalize the efficacy study in dogs, we will be in a very good position to market the material for veterinary osteoarthritis treatment,” Putnam said. From there, the human market for a lubricin substitute should follow, just as HA has been made available for human use, mainly in knees.
The Latest on: Osteoarthritis
via Google News
The Latest on: Osteoarthritis
- Aversion to Total Joint Arthroplasty: Functional Scores Predict Patient Preferenceson March 20, 2020 at 3:02 pm
The purpose of this study was to determine if there is a difference in prospectively collected osteoarthritis severity scores between patients who are averse to surgery compared with those who are ...
- High Prevalence of Osteoarthritis in Pets Underscoring Growth in Veterinary Orthopedic Implants Market from 2018 to 2026: TMRon March 17, 2020 at 4:30 am
/PRNewswire/ -- In the veterinary orthopedic implant market, robust growth is forecasted owing to multiple factors. A prominent reason supporting this ...
- Hand osteoarthritis less prevalent among black patientson March 16, 2020 at 3:06 pm
Black populations demonstrated lower odds for hand osteoarthritis, compared with nonblack groups, according to data published in Arthritis & Rheumatology. “Previous studies showed that black subjects ...
- Osteoarthritis may increase risk of death because of lack of walkingon March 15, 2020 at 2:07 am
New research has shown that people with osteoarthritis are at an increased risk of premature death and that lack of walking is the key contributing factor. Share on Pinterest Physical inactivity may ...
- Global Osteoarthritis Clinical Trials Review - H1, 2020 - ResearchAndMarkets.comon March 13, 2020 at 9:35 am
DUBLIN--(BUSINESS WIRE)--The "Osteoarthritis Global Clinical Trials Review, H1, 2020" clinical trials has been added to ResearchAndMarkets.com's offering. Summary This clinical trial report, ...
- Supplements for Osteoarthritison March 12, 2020 at 4:48 am
Osteoarthritis, which is the most common form of arthritis in many countries, is a condition characterized by functional impairment and pain in the joints. This joint pain may affect one’s daily ...
- Natural Ways to Ease Osteoarthritis Painon March 12, 2020 at 4:29 am
The risk of falls is lower and back pain is likely to be improved. It is thus not surprising that Tai Chi produces pain relief and better function in knee osteoarthritis. Acupuncture refers to the ...
- More genes associated with canine hip dysplasia and osteoarthritis discoveredon March 11, 2020 at 5:21 am
A study encompassing over 700 German shepherd dogs indicates that increased joint surface attrition is not the sole cause underlying the development of osteoarthritis associated with hip dysplasia.
- App helps reduce osteoarthritis painon March 5, 2020 at 8:40 am
"We expected patients to see an improvement, but these results exceeded our expectations. This demonstrates that using digital tools when treating chronic illnesses such as osteoarthritis can work ...
- Quantitative 3D imaging parameters improve prediction of hip osteoarthritis outcomeon March 5, 2020 at 2:18 am
Osteoarthritis is an increasingly important health problem for which the main treatment remains joint replacement. Therapy developments have been hampered by a lack of biomarkers that can reliably ...
via Bing News